Skip to content

Posts by Kevin Andrew Raskin, MD

  • Health care professionals at this year’s AAOS discussed research findings, novel treatment approaches and innovations on the podium and in the hallways. These conversations generated press across trade publications.

  • In the first genome-wide association study of fracture nonunion, researchers at Massachusetts General Hospital have identified multiple loci that warrant investigation in the effort to address this costly outcome.

  • The AAOS Annual Meeting is a global exchange for orthopaedic scientists and clinicians. Specialists from Massachusetts General Hospital will present and debate leading research and innovative treatment approaches in orthopaedic care.

  • A Mass General study found that metastatic spine patients are best evaluated using PROMIS survey results for function and pain, and SOSG-OQ survey results for quality of life.


Dr. Kevin Raskin earned a BA from University of California, Santa Barbara, in 1991 and his MD degree from Tel Aviv University in 1997. He completed his internship in general surgery and residency in orthopedic surgery at the Albert Einstein College of Medicine/Montefiore Medical Center. Dr. Raskin completed a fellowship in orthopedic oncology at Massachusetts General Hospital and has been an orthopedic oncology Surgeon at Mass General since 2003. He is a member of the Sarcoma and Connective Tissue Center and Director of the Orthopaedic Oncology Fellowship Program. He is an instructor in orthopedic surgery at Harvard Medical School, where he teaches residents, fellows and medical students both in and out of the operating room.